Global orthopedic sales totaled $62 billion in 2024, an increase of 5% compared to 2023. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
Global orthopedic sales totaled $62 billion in 2024, an increase of 5% compared to 2023. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
The company’s orthopedic sales declined about 10% in the first quarter of 2025, but its commercial channel showed ample promise.
The company grew in the low single digits for the first quarter of 2025 and expects accelerating growth through the year.
The company’s orthopedic sales declined about 10% in the first quarter of 2025, but its commercial channel showed ample promise.
The company grew in the low single digits for the first quarter of 2025 and expects accelerating growth through the year.
Stay up to date on the orthopedic market’s 1Q performance in 2025 as we update this post with company sales data and industry developments.
The company faced market softness, supply issues and international order timing lumpiness as it declined in the low single digits.
The company’s orthopedic sales grew 6% in the first quarter of 2025 on the strength of DUROLANE and Exogen.
The company grew nearly 25% in the first quarter of 2025 as its physician user base reached record levels.
The company grew in the low single digits for 1Q25 due to one less selling day and distributor team transitions.
The company grew in the low single digits in the first quarter of 2025 and it retools its U.S. sales channel.
The company grew more than 20% in the first quarter of 2025 as it seeks to cement itself as the largest pure-play spine company.
The company maintained its exceptional pace of orthopedic growth during the first quarter of 2025 driven by execution and robotic procedures.
The company grew in the low single digits in the first quarter of 2025 as it incrementally improves its performance.
The company’s orthopedic sales grew in the low single digits in the first quarter as it attempts to improve its supply chain.
Voom has developed Bunionplasty 360 Repair, featuring the Revcon Anchor Single-Screw solution combined with patented & patent-pending surgical techniques.
One-time events and competitive pressures created a slower start to 2025 for J&J MedTech’s orthopedic sales.
Smith+Nephew’s 12-Point Plan is working and driving improved performance for the company. But is it working fast enough?
Login
Register for a free account
As a guest member you get access to more articles and videos every month.